Weiting Kang

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Mitochondrial Dna

Inflammatory Response

Transcription Factor

Top Venues

Oxidative medicine and cellular longevity

BioMed research international

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang, Xunbo Jin
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF- κ B Axis". Oxidative medicine and cellular longevity 2021 (2021)
Hui Xiong, Hui Gao, Jinding Hu, Yun Dai, Hanbo Wang, Min Fu, Taiguo Qi, Lianjun Li, Qinghua Xia, Xunbo Jin, Zilian Cui, Weiting Kang
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer. Journal of oncology 2021 (2021)
Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang, Xunbo Jin
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis. Oxidative medicine and cellular longevity 2021 (2021)
Qiang Wang, Jinding Hu, Weiting Kang, Jin Wang, Yuzhu Xiang, Min Fu, Hui Gao, Zhilong Huang
Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications. Medicine 100 (11) (2021)
Weiting Kang, Meng Zhang, Qiang Wang, Da Gu, Zhilong Huang, Hanbo Wang, Yuzhu Xiang, Qinghua Xia, Zilian Cui, Xunbo Jin
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma. BioMed research international 2020 (2020)
Weiting Kang, Meng Zhang, Qiang Wang, Da Gu, Zhilong Huang, Hanbo Wang, Yuzhu Xiang, Qinghua Xia, Zilian Cui, Xunbo Jin
Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma". BioMed research international 2020 (2020)